Summary

Market Overview
The global nutraceutical excipients market was valued at USD YY million in 2022. It is forecasted to reach USD YY million by 2030, growing at a CAGR of 7.45% during the forecast period (2023-2030).
Nutraceutical excipients are inactive components prepared with Active Pharmaceutical Ingredients (API) for bulking up solutions with powerful active ingredients. These nutraceutical excipients are used in standardized and pharmaceutical-grade supplements. Nutraceutical is a term used for food or fortified food derived from food sources that supplement the diet and provide additional health benefits along with the basic nutritional value present in foods. Other terms used for nutraceuticals are "medical foods," "functional foods," "designer foods," and others. They also provide medical benefits and help treat or prevent diseases, ensuring improved health conditions. Furthermore, nutraceutical products contain various compounds unstable to heat, light, oxygen, alkaline pH, and elevated humidity. They may also have poor flow, low bulk density, and variable particle size distribution. The unstable nature of compounds is controlled by incorporating different nutraceutical excipients. It contains fillers, diluents, disintegrants, binders, coating agents, flavoring agents, colorants, sweeteners, and lubricants during the production of different supplements, such as tablets, capsules, powders, and liquid syrups.
Moreover, the increasing application of prebiotics and probiotics and the rising prevalence of lifestyle diseases across the globe are fueling the demand for nutraceutical excipients. The growing geriatric population, coupled with increasing cases of osteoporosis and cardiovascular diseases, has improved the adoption of nutritional foods and dietary supplements. The rapid adoption of dry nutraceutical excipients to curb the rising prevalence of osteoarthritis, diabetes, thyroid disease, and obesity will continue to improve the demand in the market.
Market Dynamics: Rising demand for nutraceuticals is driving the nutraceutical excipients market
Products known as nutraceuticals can be used as medicine in addition to being nutritional. A substance with physiological benefits or protection against chronic disease may be referred to as a nutraceutical product. Nutraceuticals can be used to boost well-being, slow down aging, stop chronic diseases from occurring, lengthen life expectancy, or support the body's structure or functions. Due to their potential for having nutritional, safe, and therapeutic impacts, nutraceuticals have recently attracted much attention. Although people may use pharmaceutical and nutraceutical substances to treat or prevent disease, the government only approves pharmaceutical substances. Due to their potential for having nutritional, safe, and therapeutic impacts, nutraceuticals have recently attracted much attention.
Nutraceuticals such as probiotics, which contain yeast and beneficial bacteria, are advantageous to consumers because they boost digestion, gut health, immunity, and nutrient absorption. Yogurt, beverages, and dietary supplements in tablets and capsules are just a few different formats in which they can find probiotic products. For instance, in April 2021, DFE Pharma, a leading player in pharmaceutical excipient solutions, announced the launch of its new product line, "BioHale," to cater to the worldwide demand of biopharmaceutical companies.
However, the decrease in returns on R&D investments and high clinical trials and registration costs restrain the market's growth prospects. High R&D investments give unequal returns in terms of productivity, as even after successful molecule discovery, the cost of bringing a new nutraceutical product and a new excipient to market is significantly high. At the same time, the risk of failure also remains high. The cost of proving the effectiveness of an excipient through clinical trials is also relatively expensive. It can be a major hindrance to developing novel excipients in the market.
Market Segmentation: The probiotics segment had the highest share in the nutraceutical excipients market
Probiotics are yeast and good bacteria that benefit consumers by enhancing digestion and gut health, improving immunity, increasing nutrient absorption, and lowering the chances of food allergies. Probiotic products are offered in different forms, including yogurt, drinks, and supplement forms such as tablets and capsules. However, two main challenges exist in developing a probiotic formulation viable for commercial use. The first is the quality of health attributes that the probiotic organisms can confer, and the second is the formula's stability until the end of its shelf life.
Companies are focusing on developing and offering probiotic blend products, including APIs (Active Pharmaceutical Ingredient), containing probiotic formulations using different types of excipients. Among the excipients used in these blends for the probiotic formulation, mannitol was found to be the most suitable, which helped in the enhancement of the shelf life of end-products. For instance, on September 13, 2022, Nestle’s Garden of Life launched two new probiotics for kids’ growth and immune health on China’s offline retail market. For instance, on June 1, 2022, Amway Korea launched a precision probiotics service where users send in their feces for analysis and receive recommendations on which probiotics to take to improve their gut microbiome and increase the production of beneficial short-chain fatty acids.
Geographical Penetration: North America is the dominant region during the forecast period
North America has the highest market share and a dominant position in the nutraceutical excipients market. The rise of nutraceutical excipients in the North American region has fueled the demand for functional food products. This growth has been attributed to busy lifestyles and growing consumer awareness of the health benefits of nutritional foods, including food supplements. In addition, new product launches and the use of technology have made excipients available for use in new and innovative ways. The U.S. is anticipated to dominate the North American nutraceutical excipients market owing to the increasing demand for dietary supplements across the country.
Consumers' focus on nutrition and dietary supplements has encouraged nutraceutical excipient producers to focus on innovative launches and cater to the demand in the food and beverage industry. For instance, in February 2021, Innophos announced the launch of multifunctional excipients in nutraceuticals and dietary supplements. A-TAB® MD and NUTRA-TAB® CPMEs are designed to assist manufacturers. It uses co-processed multifunctional excipients (CPMEs) to simplify labels and improve compressibility. It also reduces tablet size and increases manufacturing efficiency. The increasing prevalence of lifestyle diseases such as obesity, diabetes, and others has increased the consumption of prebiotics and probiotics in the U.S. This will subsequently create opportunities for nutraceutical excipients' application in the country's food sector. According to the Centers for Disease Control and Prevention (CDC), obesity in the U.S. was recorded at 42.4%. It is expected to rise with the fast-paced lifestyle in the country.
The market for nutraceutical excipients is anticipated to expand at the fastest rate in the Asia Pacific region. This region primarily includes China, India, and Japan. The region's food sectors, such as nutraceuticals, have promising prospects for growth and diversification as a result of the rise in income and purchasing power, the massive expansion of the middle-class population, the rise in awareness of health and fitness among consumers, and the rise in consumer consumption of nutritional and healthy products. The market players are focusing on the products in this region owing to its rising population. It boosts the demand for such products. The rising population is leading the market in a significant way as illness and problems are also rising due to various factors that spike the demand for nutraceutical excipients.
Competitive Landscape:
The major companies focusing on organic growth tactics such as new releases, product approvals, patents, and events. Acquisitions and partnership collaborations were observed as inorganic growth strategies in the industry. These initiatives have paved the way for market players to expand their businesses and client bases. Some players in the nutraceutical excipients market are DuPont, BASF SE, Kerry Group PLC, Ingredion Plc, Sensient Technologies, Associated British Foods, Roquette Freres, Meggle Group Wasser, Cargill Inc., and Ashland Global Holdings Inc. For instance, in March 2020, Azelis Chemical Limited announced the acquisition of CosBond, China, a leading specialty chemical and food ingredient distributor, to cement its dominance in China with the help of CosBond’s existing customer base. On December 19, 2019, DuPont signed an agreement to merge its Nutrition & Biosciences business with IFF (US). The combined company is valued at $45.4 billion. DuPont owned the majority of the shares, 55.4%, and IFF owned the remaining 44.6%. Both parties agreed upon it. This development is expected to help the company broaden its capabilities by offering nutritional ingredients and solutions to global consumers.
COVID-19 Impact: Positive impact on the global nutraceutical excipients market
In the wake of the COVID-19 pandemic, the demand for dietary supplements and functional foods has soared. Immunity boosting supplements have become mainstream over the past year and this has led to a significant change in buying patterns and consumer behavior. Moreover, after the COVID-19 pandemic, preventive healthcare measures such as dietary supplements will become a part of people’s everyday lives. Thus, the COVID-19 pandemic across the globe has paved the way for nutraceuticals to build a strong presence in the global market.
The global nutraceutical excipients market report would provide access to approximately 61 market data tables, 58 figures and 170 pages

ページTOPに戻る

Table of Contents